Mental Health Care study: Group Medical Visits
Official title Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression
ClinicalTrials.gov ID: NCT06651801
What this study is testing
- What it's testing
- The study wants to find out if group medical visits are practical and acceptable for patients with depression and anxiety, and to gather early data on whether they might reduce symptoms.
- Who it's for
- Adults who have depression or anxiety and are willing to try group visits.
- What's involved
- Participants are randomly assigned to either 6 months of biweekly virtual group visits or to usual care. The group visits mimic regular psychiatric check‑ups. The usual care group gets a psychiatric assessment and then standard follow‑up with their primary doctor, possible individual psychiatric care, or a referral to public therapy groups.
- Time commitment
- The study lasts 6 months, with biweekly group sessions for the intervention arm and routine follow‑up visits for the control arm.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult patients who are looking for longitudinal psychiatric follow-up after a one-time consult or discharge from a mental health program.
- Primary mental health issue is an anxiety or depressive disorder.
- Able to commit to a virtual biweekly group on Tuesdays from 2:30-4PM.
- Able to do virtual group from a private location with camera access.
- Live in community in Manitoba and plan to stay for a 6-month period.
You likely can't join if
- Patients with confirmed Bipolar 1 or 2 Disorder.
- Patients who already have longitudinal care with a psychiatrist.
- Received ECT treatment within past 6 months.
- Concern about safety of other group members/facilitators if this patient were to join.
- Severe substance use disorder.
- Significant PTSD or OCD symptoms that would impact group participation.
See the full eligibility criteria
- Adult patients who are looking for longitudinal psychiatric follow-up after a one-time consult or discharge from a mental health program.
- Primary mental health issue is an anxiety or depressive disorder.
- Able to commit to a virtual biweekly group on Tuesdays from 2:30-4PM.
- Able to do virtual group from a private location with camera access.
- Live in community in Manitoba and plan to stay for a 6-month period.
- Patients with confirmed Bipolar 1 or 2 Disorder.
- Patients who already have longitudinal care with a psychiatrist.
- Received ECT treatment within past 6 months.
- Concern about safety of other group members/facilitators if this patient were to join.
- Severe substance use disorder.
- Significant PTSD or OCD symptoms that would impact group participation.
- Severe personality disorder.
- Current psychotic symptoms.
- Moderate to severe intellectual disability or neurocognitive disorder.
- Current significant eating disorder symptoms.
- Self-harm behaviour requiring medical/psychiatric attention or suicide attempt within the past 6 months.
The study team makes the final eligibility decision.
Where it is enrolling
- Winnipeg, Manitoba, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Winnipeg, Manitoba, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.